Viatris Inc
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/303% below fair value
$20.28−0.17 (-0.83%)
Close on Nov 18, 2026Market cap $23.29BP/E –Yield 2.37%
Viatris Products in Active Development by Year
Products in Active Development — Emerging Markets
Viatris Products in Active Development: 70 in FY2025, down 6.7% from a year earlier.
Latest, FY2025
70
Period ended Dec 31, 2025
Change on a year earlier
-6.7%
75 in FY2024
History
6 years
Since FY2020
Sources
3
Documents cited below
Where the FY2025 figure comes from
“Emerging Markets 95 75 ~70”
Source: Viatris 2025 Sustainability Report ↗
Reported in Viatris Sustainability Reports.
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Products in Active Development — Emerging Markets | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 70 | -6.7% | Viatris 2025 Sustainability Report ↗ |
| FY2024 | Dec 31, 2024 | 75 | -21.1% | Viatris 2025 Sustainability Report ↗ |
| FY2023 | Dec 31, 2023 | 95 | -5.0% | Viatris 2025 Sustainability Report ↗ |
| FY2022 | Dec 31, 2022 | 100 | +42.9% | Viatris 2024 Sustainability Report ↗ |
| FY2021 | Dec 31, 2021 | 70 | -22.2% | Viatris 2023 Sustainability Report ↗ |
| FY2020 | Dec 31, 2020 | 90 | – | Viatris 2023 Sustainability Report ↗ |
Cite this data
StockData. (2026). Viatris Products in Active Development, annual FY2020–FY2025 [Data set]. Compiled from Viatris SEC filings and investor materials. https://stockdatahq.com/stocks/vtrs/kpis/prod-dev-em
See every metric in the Viatris KPI table. Data updated Nov 16, 2026.
See a number that looks wrong?